Nevirapine Hemihydrate

Nevirapine Hemihydrate is the pediatric version of the HIV drug Nevirapine. Boehringer Ingelheim, the patent-holder, has been involved in licensing arrangements and competition settlements over this drug. The Indian Patent Office rejected the patent in this case. Read more HERE.

I-MAK Patent Opposition

Pre-grant patent opposition on Nevirapine Hemihydrate [pdf]

 

Links to Selected Media on Indian Patent challenge

India rejects Boehringer's AIDS drug patent plea - The Times of India

Govt turns down German pharma firm`s patent plea - Business Standard

It's a relief for the HIV-infected - Deccan Herald

 

Competition Case and Settlement on Nevirapine

"The Competition Commission Complaint: Questions and Answers", Treatment Action Campaign [pdf]

TAC agreements with GlaxoSmithKline and Boehringer Ingelheim in force", AIDS Law Project

Boehringer Non-Assert Agreement offered to Indian companies [pdf]